Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Extrarenal TFE3-Rearranged Renal Cell Carcinoma: Diagnostic Challenges in an Uncommon Scalp Localization.

Created on 06 Oct 2026

Authors

Imane Tazi, Mohamed Allaoui, Mohamed Reda El-Ochi, Azzekhmam Mustapha, Amal Damiri, Abderrahim Elktaibi, Amine Essaoudi, Hafsa Chahdi, Mohamed Oukabli

Published in

Turk patoloji dergisi. Oct 02, 2026. Epub Oct 02, 2026.

Abstract

TFE3-rearranged renal cell carcinoma (RCC) is a rare subtype of MiT family translocation-associated tumors, usually arising in the kidney of young patients. Extrarenal presentations are exceptionally uncommon and represent a major diagnostic challenge. To our knowledge, only two cases of extrarenal TFE3-rearranged RCC have been reported in the literature to date. We report an unusual case arising in the scalp with cranial bone destruction.
A 24-year-old man presented with a rapidly enlarging occipital soft tissue mass evolving over five months. Imaging revealed a scalp tumor with lytic destruction of the cranial vault. Histologically, the tumor showed papillary and pseudopapillary architecture composed of cells with clear to eosinophilic cytoplasm and marked nuclear atypia. Immunohistochemistry demonstrated strong positivity for cytokeratins, CD10, PAX8 and TFE3, while CK7, CK20, EMA and GFAP were negative. A metastatic TFE3-rearranged RCC was initially suspected. However, extensive staging including 18F-FDG PET/CT revealed no renal primary tumor or other lesions. Based on the morphological, immunophenotypic and radiological findings, the diagnosis of extrarenal TFE3-rearranged RCC was retained.
This case highlights the diagnostic complexity of extrarenal TFE3-rearranged RCC and expands the anatomical spectrum of this entity to the scalp with bone destruction. Accurate diagnosis relies on the integration of morphology, immunohistochemistry and imaging findings.

PMID:
42836579
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement